Voyager Therapeutics (VYGR) PT Lowered to $18 at Wedbush

Go back to Voyager Therapeutics (VYGR) PT Lowered to $18 at Wedbush

Voyager Therapeutics (VYGR) PT Lowered to $27 at Baird

November 8, 2018 8:44 AM EST

Baird analyst Brian Skorney lowered the price target on Voyager Therapeutics (NASDAQ: VYGR) to $27.00 (from $31.00) while maintaining a Outperform rating.

The analyst commented, "After initially indicating that the Phase 2 study Voyager is about to start could be fileable, the FDA recently notified Voyager... More